Catamaran Corp Acquires Restat

Thursday, 1 Aug 2013 05:55am EDT 

Catamaran Corp announced that it has entered into a definitive agreement to acquire Restat, LLC one of the privately held pharmacy benefit managers, for a purchase price of $409.5 million in cash, subject to certain customary post-closing adjustments. Catamaran expects the transaction to close in the fourth quarter of 2013. 

Company Quote

-0.57 -0.89%
30 Jan 2015